Caregivers of patients receiving long-term treatment with a tyrosine kinase inhibitor (TKI) for gastrointestinal stromal tumour (GIST): a cross-sectional assessment of their distress and burden.

CONCLUSIONS: Caregivers of the patients with GIST treated with TKI are managing well. There is a small, vulnerable group of caregivers with high levels of burden and/or distress, show more health-related problems, both physical and mental, and require adequate support. PMID: 30280630 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/30280630?dopt=Abstract

Source: Acta Oncologica - October 3, 2018 Category: Cancer & Oncology Authors: Langenberg SMCH, Reyners AKL, Wymenga ANM, Sieling GCM, Veldhoven CMM, van Herpen CML, Prins JB, van der Graaf WTA Tags: Acta Oncol Source Type: research